Trillium Therapeutics Inc. (NASDAQ:TRIL) shares fell to a low of $9.69 before closing at $10.17. Intraday shares traded counted 1.17 million, which was 5.44% higher
Trillium Therapeutics Inc. (NASDAQ:TRIL) shares fell to a low of $9.34 before closing at $9.42. Intraday shares traded counted 0.78 million, which was 37.91% higher
Trillium Therapeutics Inc. (NASDAQ:TRIL) stock’s Relative Strength Index (RSI) is 61.71, with weekly volatility at 6.13% and ATR at 0.51. The TRIL stock’s 52-week price
Trillium Therapeutics Inc. (NASDAQ:TRIL) shares traded lower over the last trading session, losing -0.62% on 05/28/21. The shares fell to a low of $7.89 before
Trillium Therapeutics Inc. (NASDAQ:TRIL) previous close was $7.48 while the outstanding shares total 103.14M. TRIL’s shares traded higher over the last trading session, gaining 3.88%
Trillium receives a notable amount in equity stake from pharma giants Pfizer. Trillium Therapeutics Inc. (TRIL) shares soared almost 44% in yesterday’s trading session followed
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne
